Neuroprotection mediated by glutamate carboxypeptidase II (NAALADase) inhibition requires TGF-

By Thomas A.G.   Liu W.   Olkowski J.L.   Tang Z.   Lin Q.   Lu X.-C.M.   Slusher B.S.  

European Journal of Pharmacology, Vol. 430, Iss. 1, 2001-10 ,pp. : 33-40

Elsevier

Access to resources Recommend Favorite

Prolonged pre-exposure to 1-aminocyclopropanecarboxylic acid protects against subsequent glutamate toxicity in vitro

By Lin Y.   Long J.B.  

European Journal of Pharmacology, Vol. 338, Iss. 3, 1997-11 ,pp. : 289-292

Elsevier

Access to resources Recommend Favorite

Acute or prolonged exposure to 1-aminocyclopropanecarboxylic acid protects spinal neurons against NMDA toxicity

By Yu L.   Long J.B.  

European Journal of Pharmacology, Vol. 318, Iss. 2, 1996-12 ,pp. : 491-496

Elsevier

Access to resources Recommend Favorite

Neuroprotection afforded by NAAG and NAALADase inhibition requires glial cells and metabotropic glutamate receptor activation

By Thomas A.G.   Olkowski J.L.   Slusher B.S.  

European Journal of Pharmacology, Vol. 426, Iss. 1, 2001-08 ,pp. : 35-38

Elsevier

Access to resources Recommend Favorite

Total Bakkenolides Protects Neurons Against Cerebral Ischemic Injury Through Inhibition of Nuclear Factor-κB Activation

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 5, 2014-06 ,pp. : 874-884

Bentham Science Publishers

Access to resources Recommend Favorite